• Home
  • Point Of Care Testing Systems – GENZPRO

GENZPRO Covid-19 POC Testing System

GENZPRO SARS-CoV-2 Antibody Test is a microfluidic immunoassay for the detection of SARS-CoV-2 antibodies in whole human blood or serum to indicate recent or prior infection.

The test chip is used with the Genzpro POC device, delivering results in 7 minutes, using a cloud-based platform integrated with health system networks and transfers patient data.

Genzpro’s ELISA-based microfluidic chip is coated with Sars-Cov-2 antigens, precisely detecting targeted human IgG antibodies in one drop of blood, serum, or plasma.

GenzPro device is a connected stand-alone, portable device that analyses Genzpro’s test chip in 7 minutes, reports the results to the patient, the doctor, and/or central information systems.

Genzpro Antibody Rapid test shows the immune response of patients against the Covid-19 virus after 2-14 weeks from the infection or after vaccination in a reliable way.

The GNZ-CVD-19 Ab Test is designed to be used in community care settings to identify individuals with an adaptive immune response to COVID-19, indicating recent or prior infection, antibody therapies, or vaccination.

GENZPRO Point of Care (POC) Immunoassay Analyzer

Genz Pro device is a portable easy to use testing system optimized for outdoor use. Genz Pro reads the Ag/Ab quantity using Genz pro test chips in minutes from the client’s blood or nasal swab specimen. Test results automatically can be stored in the device and/or sent to the doctor or patients via mobile or email. Genz Pro device is a smart solution for reliable testing, and it prevents virus contamination.

The Genzpro Platform is an innovative, nextgen point of care diagnostic system that combines a small, compact device, an advanced low-cost test chip, and seamless connectivity.

The platform and tests are created on the same principles as gold standard lab analyzer systems to produce accurate results across many parameters in a portable, easy-to-use point of care solution.

Request Demo